Belatacept Clinical Trials
6 recruitingDrug
Phase 24Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 2
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Immunosuppression
Linda Cendales50 enrolled1 locationNCT02310867
Recruiting
Phase 2
Belatacept in Heart Transplantation
Heart Transplant
National Institute of Allergy and Infectious Diseases (NIAID)66 enrolled5 locationsNCT06478017
Recruiting
Phase 2
Advancing Transplantation Outcomes in Children
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled20 locationsNCT06055608
Recruiting
Phase 3
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Renal Allograft Recipients
Bristol-Myers Squibb102 enrolled38 locationsNCT04877288
Recruiting
Phase 2
Belatacept in De Novo Heart Transplantation
Heart Transplantation
NYU Langone Health12 enrolled2 locationsNCT04477629
Recruiting
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Kidney Transplant Infection
University Hospital, Rouen28 enrolled1 locationNCT05708534